Vertex’s second transformation: Duchenne time
The cystic fibrosis player does deals with Crispr and Exonics to launch itself into a highly competitive rare disease area.
The cystic fibrosis player does deals with Crispr and Exonics to launch itself into a highly competitive rare disease area.